A detailed history of Investment Advisory Services Inc transactions in Amgen Inc stock. As of the latest transaction made, Investment Advisory Services Inc holds 5,830 shares of AMGN stock, worth $1.81 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
5,830
Previous 6,130 4.89%
Holding current value
$1.81 Million
Previous $1.77 Million 6.12%
% of portfolio
0.61%
Previous 0.7%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$268.87 - $324.56 $80,661 - $97,368
-300 Reduced 4.89%
5,830 $1.66 Million
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $7,159 - $8,076
28 Added 0.46%
6,130 $1.77 Million
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $874 - $1,085
4 Added 0.07%
6,102 $1.64 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $4,499 - $5,320
21 Added 0.35%
6,098 $1.35 Million
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $5,644 - $6,880
25 Added 0.41%
6,077 $1.47 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $23,532 - $26,187
102 Added 1.71%
6,052 $1.47 Million
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $35,083 - $38,811
160 Added 2.76%
5,950 $1.44 Million
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $27,246 - $31,181
-137 Reduced 2.31%
5,790 $1.3 Million
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $6,368 - $7,461
30 Added 0.51%
5,927 $1.26 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $110,950 - $123,091
-475 Reduced 7.45%
5,897 $1.44 Million
Q3 2020

Mar 10, 2021

BUY
$234.65 - $260.95 $38,482 - $42,795
164 Added 2.64%
6,372 $1.62 Million
Q2 2020

Mar 10, 2021

SELL
$197.81 - $242.74 $19,781 - $24,274
-100 Reduced 1.59%
6,208 $1.46 Million
Q1 2020

Mar 10, 2021

SELL
$182.24 - $241.7 $36,448 - $48,340
-200 Reduced 3.07%
6,308 $1.28 Million
Q4 2019

Mar 10, 2021

BUY
$189.21 - $243.2 $1.23 Million - $1.58 Million
6,508 New
6,508 $1.57 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Investment Advisory Services Inc Portfolio

Follow Investment Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Advisory Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investment Advisory Services Inc with notifications on news.